申请人:UCHICAGO ARGONNE, LLC
公开号:US10556917B1
公开(公告)日:2020-02-11
Carbonate esters of Formula (I): (R1)(R2)(R3)Si—R4—O—C(═O)—O—R4—Si(R1)(R2)(R3) are prepared by reaction of a silyl-substituted alcohol of Formula (II): (R1)(R2)(R3)Si—R4—OH with an activated carbonyl compound of Formula (III): C(═O)Z2 in the presence of a catalyst (e.g., an bicyclic amidine, a bicyclic guanidine, or a phosphazene) in an aprotic solvent. In Formulas (I) and (II) each of R1 and R2 independently is alkyl; R3 is alkyl or —X1—Si(R5)(R6)(R7); X1 is O or alkylene; R4 is alkylene; and each R5, R6, and R7 independently is alkyl. In Formula (III), Z is 1-N-imidazolyl or 1-N-succinimidyl. In some embodiments, the catalyst used in the methods described herein comprises at least one base selected from the group consisting of a bicyclic amidine and a bicyclic guanidine. The reaction proceeds readily under both bulk and continuous flow reactor conditions.
公式(I)的碳酸酯:(R1)(R2)(R3)Si—R4—O—C(═O)—O—R4—Si(R1)(R2)(R3)是通过在无水溶剂中存在催化剂(例如双环胺、双环胍或磷氮烷)的情况下,将公式(II)的硅烷基取代醇:(R1)(R2)(R3)Si—R4—OH与公式(III)的活化羰基化合物:C(═O)Z2反应制备的。在公式(I)和(II)中,每个R1和R2独立地是烷基;R3是烷基或—X1—Si(R5)(R6)(R7);X1是O或烷基;R4是烷基;每个R5、R6和R7独立地是烷基。在公式(III)中,Z是1-N-咪唑基或1-N-琥珀酰亚胺基。在某些实施方式中,所述方法中使用的催化剂包括从双环胺和双环胍组中选择的至少一种碱。反应在大块和连续流反应器条件下均能顺利进行。